MELVILLE, N.Y. – April 1, 2015 – Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today the completion of its acquisition of scil animal care company GmbH. scil animal care is a highly specialized distributor of animal health laboratory and imaging diagnostic products and services to veterinarians primarily in North America and Europe. This transaction was announced on January 19, 2015.
scil animal care had sales for the 12 months ended December 31, 2014 of approximately $82.6 million (EUR 62.2 million). As previously reported, Henry Schein expects the acquisition to be slightly dilutive to its 2015 earnings per share.
“We extend a warm welcome to our new colleagues from scil animal care as we expand our Animal Health equipment capabilities in North America and Europe with the addition of their specialty diagnostics distribution business,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, Inc. “Diagnostics are critical in helping veterinarians provide high-quality care and increasing practice revenues. Adding scil animal care significantly expands our capabilities and helps us to gain market share for our existing animal health diagnostics partners. Furthermore, we are committed to tight and seamless connectivity for our veterinary customers to our practice management systems, including AVImark® and ImproMed®.”
The addition of scil animal care adds Canada, Italy and Malaysia to the list of countries where Henry Schein Animal Health serves veterinary customers. Henry Schein Animal Health currently serves veterinary customers in 12 European countries, including Austria, Belgium, the Czech Republic, France, Germany, the Netherlands, Ireland, Poland, Portugal, Spain, Switzerland and the United Kingdom. Henry Schein Animal Health also has businesses in the United States, Australia and New Zealand. In 2014, Henry Schein's global Animal Health business had sales of approximately $2.9 billion.
The addition of scil animal care brings the total number of countries where Henry Schein, Inc. has operations or affiliates to 29, the newest being Malaysia. Founded in 1998 with headquarters in Viernheim, Germany, scil animal care sells, services and supports laboratory diagnostic and imaging solutions to veterinarians in the United States, Canada, Germany, France, Italy, the Netherlands, Malaysia and Spain, with a distribution presence in 25 additional countries. In addition to the selection of products it offers customers, scil animal care provides product installation and training, loaner and repair services, as well as a broad array of educational programs. Among scil animal care's more than 200 employees are 32 veterinarians, 26 equipment specialists and more than 70 sales representatives.
About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member of the S&P 500® and NASDAQ 100® Indices, Henry Schein employs approximately 18,000 Team Schein Members and serves more than 1 million customers. The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and Henry Schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services. Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 29 countries. The Company's sales reached a record $10.4 billion in 2014, and have grown at a compound annual rate of approximately 16% since Henry Schein became a public company in 1995. For more information, visit the Henry Schein website at www.henryschein.com.
Executive Vice President and Chief Financial Officer
Vice President, Investor Relations
Vice President, Corporate Communications